Skip to main content

Experiences in implementation of routine human immunodeficiency virus testing in a US tuberculosis clinic

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: Rhode Island Tuberculosis (RI TB) Clinic, The Miriam Hospital, Providence, RI, USA.

BACKGROUND: Human immunodeficiency virus (HIV) status is a critical factor in the management of both patients with latent TB infection (LTBI) and active TB. Since 2006, the Centers for Disease Control and Prevention has recommended routine, opt-out HIV testing in all health care settings, including TB clinics. However, implementation of HIV testing in LTBI patients has been limited.

DESIGN: A policy for HIV assessment of all new patients was instituted at the RI TB Clinic. Patients who reported no HIV testing in the preceding year were offered opt-out HIV testing. Patient records (June 2010–June 2011) were retrospectively reviewed. Structured nursing interviews assessed staff acceptance.

RESULTS: A total of 821 (77.5%) first-visit TB patients underwent HIV status assessment: 96.3% of those not tested in the previous year agreed to testing; 65.9% of tests were performed at point of care. There was one new HIV diagnosis.

CONCLUSION: Implementing routine opt-out HIV testing in the RI TB Clinic is feasible, with high staff acceptance rates and low patient refusal rates. Perceived health systems barriers can be overcome. Incorporating opt-out HIV testing for LTBI patients expands testing opportunities to individuals unaware of their HIV status, and can identify HIV-infected patients early in the course of infection.

Keywords: LTBI; barriers; implementation; point-of-care; uninsured

Document Type: Research Article

Affiliations: 1: Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA; The Miriam Hospital, Providence, Rhode Island, USA 2: Brown University, Providence, Rhode Island, USA 3: The Miriam Hospital, Providence, Rhode Island, USA

Publication date: 01 September 2012

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content